1. •• Lynch JP 3rd, Kajon AE. Adenovirus: epidemiology, global spread of novel serotypes, and advances in treatment and prevention. Semin Respir Crit Care Med. 2016;37(4):586–602 Comprehensive review on HAdV epidemiology, treatment and prevention.
2. • Lion T. Adenovirus infections in immunocompetent and immunocompromised patients. Clin Microbiol Rev. 2014;27(3):441–62 Comprehensive review on HAdV pathogenesis, diagnostics and treatment.
3. Stephenson KE, Rhee EG, Barouch DH. Adenoviruses. In: Bennett JE, Raphael D, Blaser MJ, editors. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. 9th ed. Philadelphia: Elsevier; 2020. p. 1908–15.
4. Rowe W, Huebner R, Gilmore L, Parrott R, Ward T. Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture. Proc Soc Exp Biol Med. 1953;84(3):570–3.
5. • Shachor-Meyouhas Y, Hadash A, Kra-Oz Z, Shafran E, Szwarcwort-Cohen M, Kassis I. Adenovirus respiratory infection among immunocompetent patients in a pediatric intensive care unit during 10-year period: co-morbidity is common. Isr Med Assoc J. 2019;21(9):595–8 Large retrospective review of immunocompetent children admitted with severe HAdV infection in a pediatric intensive care unit over a 10-year period.